Publication | Closed Access

Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus

NeurophysiologyNeuroanatomyMedicineNeurotransmitterPharmacologyNeuropharmacologyKynurenine 3-Mono-oxygenase InhibitorsNeuroscienceNeurotransmissionCentral Nervous SystemDopamineMolecular NeurobiologyBasal GangliaNeurochemistryGlutamate ConcentrationSocial Sciences